Literature DB >> 1988513

The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk.

H Fahrer1, S M van der Linden, M J Sauvain, L Gern, E Zhioua, A Aeschlimann.   

Abstract

A past history of clinical Lyme borreliosis and the 6-month incidence of clinical and asymptomatic Lyme borreliosis was studied prospectively in a high-risk population. In the spring, blood samples were drawn from 950 Swiss orienteers, who also answered a questionnaire. IgG anti-Borrelia burgdorferi antibodies were detected by ELISA. Positive IgG antibodies were seen in 248 (26.1%), in contrast to 3.9%-6.0% in two groups of controls (n = 101). Of the orienteers, 1.9%-3.1% had a past history of definite or probable clinical Lyme borreliosis. Six months later a second blood sample was obtained from 755 participants, 558 (73.9%) of whom were seronegative initially; 45 (8.1%) had seroconverted from negative to positive. Only 1 (2.2%) developed clinical Lyme borreliosis. Among all participants, the 6-month incidence of clinical Lyme borreliosis was 0.8% (6/755) but was much higher (8.1%) for asymptomatic seroconversion (45/558). In conclusion, positive Lyme serology was common in Swiss orienteers, but clinical disease occurred infrequently.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988513     DOI: 10.1093/infdis/163.2.305

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

Review 1.  Occupational risk of Lyme disease: an epidemiological review.

Authors:  J D Piacentino; B S Schwartz
Journal:  Occup Environ Med       Date:  2002-02       Impact factor: 4.402

2.  Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden.

Authors:  R Gustafson; B Svenungsson; M Forsgren; A Gardulf; M Granström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

Review 3.  Lyme disease in paediatrics.

Authors:  B Cryan; D J Wright
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

4.  Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.

Authors:  J Ma; C Gingrich-Baker; P M Franchi; P Bulger; R T Coughlin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals?

Authors:  H Fahrer; M J Sauvain; E Zhioua; C Van Hoecke; L E Gern
Journal:  Eur J Epidemiol       Date:  1998-02       Impact factor: 8.082

Review 6.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

7.  Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease.

Authors:  Fatos Onen; Dilek Tuncer; Servet Akar; Merih Birlik; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2003-04-08       Impact factor: 2.631

8.  Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis.

Authors:  S Brettschneider; H Bruckbauer; N Klugbauer; H Hofmann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite.

Authors:  I Nahimana; L Gern; D S Blanc; G Praz; P Francioli; O Péter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-24       Impact factor: 3.267

10.  Follow-up of Bernese Mountain dogs and other dogs with serologically diagnosed Borrelia burgdorferi infection: what happens to seropositive animals?

Authors:  Bernhard Gerber; Katharina Haug; Simone Eichenberger; Claudia E Reusch; Max M Wittenbrink
Journal:  BMC Vet Res       Date:  2009-05-08       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.